Skip to main content
SpringerLink
Log in

Other Glomerular Diseases

  • Chapter
  • First Online:
Core Concepts in Parenchymal Kidney Disease

  • 1292 Accesses

Abstract

Human glomerular diseases are extremely heterogenous. This chapter will deal with several of the uncommon forms of glomerular diseases not covered elsewhere in this monograph including collagenofibrotic glomerulopathy, lipoprotein glomerulopathy, C1q nephropathy, idiopathic nodular glomerulosclerosis, and immunotactoid/fibrillary glomerulonephritis. The clinical and pathological features, diagnosis, prognosis, and treatment (if any) will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ponticelli C, Glassock RJ. Other primary glomerular diseases. In: Ponticelli C, Glassock R, editors. Treatment of primary glomerular diseases. 2nd ed. Oxford: Oxford Medical; 2009. p. 435–70 (Chap. 11).

    Chapter  Google Scholar 

  2. Gubler MC, Dommergues JP, Foulard M, et al. Collagen type III glomerulopathy: a new type of hereditary nephropathy. Pediatr Nephrol. 1993;7:354–60.

    Article  PubMed  CAS  Google Scholar 

  3. Patrol KC, Jha R, Sahay M, Swamaltha G. Collagenofibrotic glomerulopathy—case report with review of the literature. Indian J Nephrol. 2011;21:52–5.

    Article  Google Scholar 

  4. Imbasciati E, Gherardi G, Morozumi K, et al. Collagen type III glomerulopathy: a new idiopathic glomerular disease. Am J Nephrol. 1991;11:422–9.

    Article  PubMed  CAS  Google Scholar 

  5. Alchi B, Nishi S, Narita I, Gejyyo F. Collagenofibrotic glomerulopathy: clinicopathologic overview of a rare glomerular disease. Am J Kidney Dis. 2007;49:499–506.

    Article  PubMed  CAS  Google Scholar 

  6. Tsimihodimos V, Elisaf M. Lipoprotein glomerulopathy. Curr Opin Lipidol. 2011;22:262–9.

    Article  PubMed  CAS  Google Scholar 

  7. Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47:199–211.

    Article  PubMed  CAS  Google Scholar 

  8. Sam R, Wu H, Yue L, et al. Lipoprotein glomerulopathy: a new lipoprotein E mutation with enhanced glomerular binding. Am J Kidney Dis. 2006;47:539–48.

    Article  PubMed  Google Scholar 

  9. Zhang B, Liu ZH, Zeng CH, et al. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy. J Nephrol. 2008;21:110–7.

    PubMed  Google Scholar 

  10. Kanamaru Y, Nakao A, Shirato I, et al. Chronic graft-versus host autoimmune disease in Fc receptor γ chain-deficient mice results in lipoprotein glomerulopathy. J Am Soc Nephrol. 2002;13:1527–33.

    Article  PubMed  CAS  Google Scholar 

  11. Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sendai (arginine 145proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 1997;8:820–3.

    PubMed  CAS  Google Scholar 

  12. Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis. 2003;41:244–9.

    Article  PubMed  Google Scholar 

  13. Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, Albertazzi A. Lipoprotein glomerulopathy treated with LDL-apheresis (heparin induced extra-corporeal lipoprotein precipitation system): a case report. J Med Case Rep. 2009;3:9311.

    Article  PubMed  Google Scholar 

  14. Hamatani H, Hiromura K, Kobatake K, Yoshida H, Kobayashi S, Yoneda N, et al. Successful treatment of lipoprotein glomerulopathy in a daughter and mother using niceritrol. Clin Exp Nephrol. 2010;14:619–24.

    Article  PubMed  Google Scholar 

  15. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985;6:103–10.

    PubMed  CAS  Google Scholar 

  16. Jennette JC, Hipp CG. Immunohistological evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol. 1985;83:415–20.

    PubMed  CAS  Google Scholar 

  17. Jennette JC, Falk RJ. Textbook of nephrology. In: Massry S, Glassock R, editors. Part 11 C1q nephropathy. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001. p. 730–3.

    Google Scholar 

  18. Markowitz GS, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64:1232–40.

    Article  PubMed  CAS  Google Scholar 

  19. Nishida M, et al. C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol. 2005;20:1669–70.

    Article  PubMed  Google Scholar 

  20. Mubarak M. C1q nephropathy presenting as acute renal failure. Saudi J Kidney Dis Transpl. 2011;22:1046–7.

    PubMed  Google Scholar 

  21. Bhowmik DM, Jain S, Dinda A, Sharma A, Mahajan S, Agarwal SK. C1q nephropathy presenting as nephritic-nephrotic syndrome. Saudi J Kidney Dis Transpl. 2011;22:561–3.

    PubMed  Google Scholar 

  22. Imai H, et al. Pan-nephritis (glomerulonephritis, arteriolitis and tubulo-interstitial nephritis) associated with predominant mesangial C1q deposition and hypocomplementemia: a variant type of C1q nephropathy. Am J Kidney Dis. 1996;27:583–7.

    Article  PubMed  CAS  Google Scholar 

  23. Fukuma Y, et al. Clinicopathologic correlations of C1q nephropathy in children. Am J Kidney Dis. 2006;47:412–8.

    Article  PubMed  Google Scholar 

  24. Lau KK, et al. C1q nephropathy: features at presentation and outcome. Pediatr Nephrol. 2005;20:744–9.

    Article  PubMed  Google Scholar 

  25. Reeves-Daniel AM, Iskanar SS, Bowden DW, Boistrom MA, Hicks PJ, Comeau ME, Langefeld CD, Freedman BI. Is collapsing C1q nephropathy another MYH9(−associated kidney disease?- a case report. Am J Kidney Dis. 2010;55:e21–e324.

    Article  PubMed  Google Scholar 

  26. Nishida M, et al. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis. 2000;35:e22.

    Article  PubMed  CAS  Google Scholar 

  27. Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC. Resolution of clinical and pathologic features of C1q nephropathy after Rituximab therapy. Clin Exp Nephrol. 2011;15:164–70.

    Article  PubMed  Google Scholar 

  28. Said SM, Cornell LD, Valeri AM, Sethi AM, Fidler ME, Cosio FG, Nasr SH. C1q deposition in the renal allograft. Mod Pathol. 2010;23:1080–8.

    Article  PubMed  Google Scholar 

  29. Herzenberg AM, et al. Idiopathic nodular glomerulosclerosis. Am J Kidney Dis. 1999;34:560–4.

    Article  PubMed  CAS  Google Scholar 

  30. Markowitz GS, et al. Idiopathic nodular glomerulosclerosis is a distinct clinico-pathologic entity linked to hypertension and smoking. Hum Pathol. 2002;33:826–35.

    Article  PubMed  Google Scholar 

  31. Navantheethan SD, Singh S, Choudry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of the literature. J Nephrol. 2005;18:613–5.

    Google Scholar 

  32. Nasr SH, D’Agati VD. Nodular glomerulosclerosis in the non-diabetic smoker. J Am Soc Nephrol. 2007;18:2032–6.

    Article  PubMed  Google Scholar 

  33. Ots M, et al. Non-diabetic nodular glomerulosclerosis recurring in a renal graft. Nephrol Dial Transplant. 2000;15:2053–6.

    Article  PubMed  CAS  Google Scholar 

  34. Alpers CE, Kowalewska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 2008;19:34–7.

    Article  PubMed  Google Scholar 

  35. Bridoux F, Hugue V, Coldefy O, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int. 2002;62:1764–75.

    Article  PubMed  CAS  Google Scholar 

  36. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993;22:367–77.

    PubMed  CAS  Google Scholar 

  37. Ivanyi B, Degrell P. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. Nephrol Dial Transplant. 2004;19:2166–70.

    Article  PubMed  Google Scholar 

  38. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450–61.

    Article  PubMed  Google Scholar 

  39. Schwartz MM, Korbet SM, Lewis EJ. Immunotactoid glomerulopathy. J Am Soc Nephrol. 2002;13:1390–7.

    Article  PubMed  Google Scholar 

  40. Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, Fervenza F. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6:775–84.

    Article  PubMed  Google Scholar 

  41. Collins M, Navaneethan SD, Chung M, Sloan J, Goldman B, Appel G, Rovin BH. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008;52:1158–62.

    Article  PubMed  CAS  Google Scholar 

  42. Samaniego M, Nadasdy GM, Laszik Z, Nadasdy T. Outcome of renal transplantation in fibrillary glomerulonephritis. Clin Nephrol. 2001;55:159–66.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geffen School of Medicine at UCLA, Laguna Niguel, CA, USA

    Richard J. Glassock M.D., M.A.C.P.

Authors
  1. Richard J. Glassock M.D., M.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard J. Glassock M.D., M.A.C.P. .

Editor information

Editors and Affiliations

  1. Div. Nephrology & Hypertension, Mayo Clinic Dept. Internal Medicine, Rochester, Minnesota, USA

    Fernando C. Fervenza

  2. Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, USA

    Julie Lin

  3. Mayo Clinic, Rochester, Minnesota, USA

    Sanjeev Sethi

  4. Renal Division, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, USA

    Ajay K. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Glassock, R.J. (2014). Other Glomerular Diseases. In: Fervenza, F., Lin, J., Sethi, S., Singh, A. (eds) Core Concepts in Parenchymal Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8166-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8166-9_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8165-2

  • Online ISBN: 978-1-4614-8166-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation